Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
The 4.5 mg dose produced 10.8% mean weight loss at 26 weeks
Recalls & Warnings September 12, 2012 Distribution of Weight Loss Product Containing DMAA Should Be Stopped Immediately, Warns FDA On August 28, 2012, the FDA issued a warning letter to Regeneca stating that the company's RegeneSlim, which was promoted as a dietary supplement for weight loss, is adulterated with dimethylamylamine (DMAA) and that failure to immediately cease distribution of this product could result in FDA
BPC-157 accelerates tissue repair while TB-500 reduces inflammation and enhances cellular migration, creating optimal conditions for healing
Subcutaneous injection of peptides typically achieves high systemic bioavailability because the peptide bypasses first-pass metabolism and gut proteolysis entirely
Not intended for medical, diagnostic, therapeutic, or human consumption use
Systemic Injection One of BPC-157s interesting properties is its ability to migrate toward areas of tissue damage regardless of injection site
